Juno Bio
UK-founded women’s health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women’s health.
Juno Bio has raised €3.3M across 1 funding round from 4 investors, most recently a round in Jul 2026. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.juno.bio ↗
Total raised
€3.3M
€3,313,857
Funding rounds
1
Investors
4
distinct backers
Active since
2026-07
latest 2026-07
Funding by year
EUR raised per year · 2026 YTDJuno Bio — funding by year — interactive chart.
Data table
| Juno Bio — funding by year | |
|---|---|
| 2026 | €3.3M |
Signals
High confidenceRaise-next likelihood17
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-16 | Other | €3.3M | Ada Ventures,Artesian VC,Entrepreneur First,Illumina Accelerator | View deal → |